Literature DB >> 18627648

Novel techniques to study visceral hypersensitivity in irritable bowel syndrome.

Trinh T Truong1, Bruce D Naliboff, Lin Chang.   

Abstract

Visceral hypersensitivity has emerged as a key hypothesis in explaining the painful symptoms of irritable bowel syndrome (IBS), and it has been proposed as a "biologic marker" for the condition. Visceral hypersensitivity can be influenced by peripheral and central mechanisms affecting pain perception. The optimal method for its assessment in humans has not been determined. Current techniques include stimulation via the computerized barostat and electrical stimulation, response measures including the lower limb reflex, and brain imaging modalities such as functional MRI and positron emission tomography. It has been shown that IBS patients have decreased sensory thresholds to colonic and rectal balloon distention by barostat. Studies using electrical stimulation and the RIII lower limb reflex have further confirmed enhanced visceral perception in IBS. Evidence from more recent neuro-imaging studies suggests that IBS patients have abnormal activation of brain circuits involved in emotional and cognitive modulation of sensory information, resulting in ineffective pain modulation; these circuits may have a pathophysiologic role in enhancing visceral perception. There are few effective pharmacologic treatments that relieve IBS symptoms, and improved understanding of brain-gut interactions and factors relating to enhanced visceral perception may guide us in developing more efficacious treatments.

Entities:  

Mesh:

Year:  2008        PMID: 18627648     DOI: 10.1007/s11894-008-0071-2

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  57 in total

1.  Activation of the mucosal immune system in irritable bowel syndrome.

Authors:  Vinton S Chadwick; Wangxue Chen; Dairu Shu; Barbara Paulus; Peter Bethwaite; Andy Tie; Ian Wilson
Journal:  Gastroenterology       Date:  2002-06       Impact factor: 22.682

Review 2.  A systematic review of neuroimaging data during visceral stimulation.

Authors:  Stuart W G Derbyshire
Journal:  Am J Gastroenterol       Date:  2003-01       Impact factor: 10.864

Review 3.  Neuroimaging of the brain-gut axis: from basic understanding to treatment of functional GI disorders.

Authors:  Emeran A Mayer; Bruce D Naliboff; A D Bud Craig
Journal:  Gastroenterology       Date:  2006-12       Impact factor: 22.682

4.  Tegaserod, a 5-HT4 receptor partial agonist, decreases sensitivity to rectal distension in healthy subjects.

Authors:  B Coffin; J-P Farmachidi; P Rueegg; A Bastie; D Bouhassira
Journal:  Aliment Pharmacol Ther       Date:  2003-02-15       Impact factor: 8.171

5.  Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention.

Authors:  H Mertz; V Morgan; G Tanner; D Pickens; R Price; Y Shyr; R Kessler
Journal:  Gastroenterology       Date:  2000-05       Impact factor: 22.682

6.  Cognitive therapy for irritable bowel syndrome is associated with reduced limbic activity, GI symptoms, and anxiety.

Authors:  Jeffrey M Lackner; Mary Lou Coad; Howard R Mertz; David S Wack; Leonard A Katz; Susan S Krasner; Rebecca Firth; Thomas C Mahl; Alan H Lockwood
Journal:  Behav Res Ther       Date:  2005-07-21

7.  Cortical effects of anticipation and endogenous modulation of visceral pain assessed by functional brain MRI in irritable bowel syndrome patients and healthy controls.

Authors:  Guang Hui Song; Vinod Venkatraman; Khek Yu Ho; Michael W L Chee; Khay Guan Yeoh; Clive H Wilder-Smith
Journal:  Pain       Date:  2006-07-18       Impact factor: 6.961

8.  Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress.

Authors:  I Posserud; P Agerforz; R Ekman; E S Björnsson; H Abrahamsson; M Simrén
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

9.  Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome.

Authors:  J Ritchie
Journal:  Gut       Date:  1973-02       Impact factor: 23.059

Review 10.  Functional GI disorders: from animal models to drug development.

Authors:  E A Mayer; S Bradesi; L Chang; B M R Spiegel; J A Bueller; B D Naliboff
Journal:  Gut       Date:  2007-10-26       Impact factor: 23.059

View more
  5 in total

Review 1.  Pain perception during menstrual cycle.

Authors:  Marina de Tommaso
Journal:  Curr Pain Headache Rep       Date:  2011-10

Review 2.  Do fluctuations in ovarian hormones affect gastrointestinal symptoms in women with irritable bowel syndrome?

Authors:  Margaret M Heitkemper; Lin Chang
Journal:  Gend Med       Date:  2009

3.  Evidence for alterations in central noradrenergic signaling in irritable bowel syndrome.

Authors:  Steven Berman; Brandall Suyenobu; Bruce D Naliboff; Joshua Bueller; Jean Stains; Heng Wong; Mark Mandelkern; Leah Fitzgerald; Gordon Ohning; Arpana Gupta; Jennifer S Labus; Kirsten Tillisch; Emeran A Mayer
Journal:  Neuroimage       Date:  2012-08-21       Impact factor: 6.556

4.  Efficacy of tricyclic antidepressants in irritable bowel syndrome: a meta-analysis.

Authors:  Roja Rahimi; Shekoufeh Nikfar; Ali Rezaie; Mohammad Abdollahi
Journal:  World J Gastroenterol       Date:  2009-04-07       Impact factor: 5.742

Review 5.  Focus on the use of antidepressants to treat pediatric functional abdominal pain: current perspectives.

Authors:  Silvana Bonilla; Samuel Nurko
Journal:  Clin Exp Gastroenterol       Date:  2018-09-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.